Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.0%

75 terminated/withdrawn out of 1254 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

14%

175 trials in Phase 3/4

Results Transparency

4%

28 of 678 completed trials have results

Key Signals

140 recruiting28 with results68 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
486(53.2%)
Phase 2
143(15.7%)
Phase 4
120(13.1%)
Phase 1
102(11.2%)
Phase 3
55(6.0%)
Early Phase 1
7(0.8%)
913Total
N/A(486)
Phase 2(143)
Phase 4(120)
Phase 1(102)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1254)

Showing 20 of 1254 trials
NCT06573866Not ApplicableActive Not Recruiting

Enhancement of Quality of Work And Life

Role: lead

NCT03981575Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Role: collaborator

NCT05186064Not ApplicableCompleted

Glioblastoma Targeted Treatment Option Maximization by WGS

Role: collaborator

NCT07625488Enrolling By Invitation

Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)

Role: lead

NCT05256199Not ApplicableActive Not Recruiting

Dutch Multidomain Lifestyle Intervention in Older Adults at Risk of Cognitive Decline

Role: collaborator

NCT05529927Phase 2Recruiting

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Role: collaborator

NCT04107636Not ApplicableCompleted

Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance

Role: lead

NCT07609901Phase 3Not Yet Recruiting

Preventive Dendritic Cell Vaccination for Lynch Syndrome Carriers

Role: lead

NCT07582458Phase 2Not Yet Recruiting

Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)

Role: lead

NCT07556887Not ApplicableRecruiting

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Role: collaborator

NCT06805396Phase 2Recruiting

Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: A Randomized Trial

Role: collaborator

NCT06636370Not ApplicableRecruiting

Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial

Role: collaborator

NCT05220163Not ApplicableActive Not Recruiting

Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Role: collaborator

NCT05575323Not ApplicableRecruiting

Randomized Trial on Same-day SBRT and Surgical Stabilization for Symptomatic Spinal Metastases

Role: collaborator

NCT04303104Not ApplicableCompleted

Xpert Active Case-finding Trial 3 (XACT-3)

Role: collaborator

NCT05331456Not ApplicableCompleted

Alveolar Cleft Repair Using Osteoinductive Ceramics

Role: collaborator

NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT07412197Phase 1Not Yet Recruiting

Preventive Dendritic Cell Vaccination for Lynch Syndrome

Role: lead

NCT05537220Phase 3Active Not Recruiting

Oral N-acetylcysteine for Retinitis Pigmentosa

Role: collaborator

NCT07560748Not Yet Recruiting

Prospective Prostate Cancer Infrastructure

Role: lead